AngioDynamics, Inc. (ANGO) Fair Value 2026 — DCF & Multi-Method Analysis | EvidInvest | EvidInvest

ANGO — Fair Value Analysis

AngioDynamics, Inc.

Current: $16.07Overvalued

Fair Value Range

Bear Case (25th pct.)

$-2.52

-115.7% vs price

Base Case (Median)

$0.05

-99.7% vs price

Bull Case (75th pct.)

$0.15

-99.1% vs price

$-2.52$0.05$0.15

◇ = Current price | |Bear |Base | Bull

Method Breakdown

Method	Est. Value	vs Price	Weight
DCF (Discounted Cash Flow)	$-5.09	-131.7%	High (40%)
EV/EBITDA	$0.05	-99.7%	Medium (20%)
EV/FCF	$0.25	-98.5%	Medium (20%)

Interpretation

Based on 3 out of 8 methods, ANGO appears overvalued at the current price of $16.07. The base case fair value of $0.05 implies 99.7% downside.

Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.